1. Home
  2. NX vs LXEO Comparison

NX vs LXEO Comparison

Compare NX & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

N/A

Current Price

$17.11

Market Cap

797.0M

Sector

Industrials

ML Signal

N/A

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

N/A

Current Price

$7.42

Market Cap

731.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NX
LXEO
Founded
1927
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
797.0M
731.3M
IPO Year
2008
2023

Fundamental Metrics

Financial Performance
Metric
NX
LXEO
Price
$17.11
$7.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$28.00
$18.60
AVG Volume (30 Days)
493.5K
605.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.84%
N/A
EPS Growth
N/A
75.08
EPS
N/A
N/A
Revenue
$1,837,641,000.00
$654,000.00
Revenue This Year
$3.18
N/A
Revenue Next Year
$2.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.81
N/A
52 Week Low
$11.04
$1.45
52 Week High
$22.90
$10.99

Technical Indicators

Market Signals
Indicator
NX
LXEO
Relative Strength Index (RSI) 27.59 55.35
Support Level $16.09 $6.90
Resistance Level $19.88 $7.72
Average True Range (ATR) 0.89 0.46
MACD -0.66 0.13
Stochastic Oscillator 7.41 71.90

Price Performance

Historical Comparison
NX
LXEO

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: